We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$146M
Cap. Flow
+$287M
Cap. Flow %
2.07%
Top 10 Hldgs %
11.54%
Holding
3,080
New
521
Increased
857
Reduced
739
Closed
172

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
TXN icon
Texas Instruments
TXN
+$39.6M
3
CHD icon
Church & Dwight Co
CHD
+$39.1M
4
BA icon
Boeing
BA
+$34.3M
5
DIS icon
Walt Disney
DIS
+$34M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$47.1M
2
AMP icon
Ameriprise Financial
AMP
+$42.3M
3
NTAP icon
NetApp
NTAP
+$38.1M
4
SYK icon
Stryker
SYK
+$35.6M
5
BALL icon
Ball Corp
BALL
+$34.9M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.66%
3 Industrials 11%
4 Financials 10.76%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIS icon
1326
iShares MSCI Israel ETF
EIS
$892M
$87K ﹤0.01%
1,700
TRGP icon
1327
Targa Resources
TRGP
$57.4B
$87K ﹤0.01%
978
-90
-8% -$8.79K
AMG icon
1328
Affiliated Managers Group
AMG
$9.61B
$86K ﹤0.01%
396
-35,222
-99% -$7.83M
CEF icon
1329
Sprott Physical Gold and Silver Trust
CEF
$7.49B
$86K ﹤0.01%
7,500
-3,250
-30% -$38.9K
MPT
1330
Medical Properties Trust
MPT
$2.86B
$86K ﹤0.01%
6,650
STWD icon
1331
Starwood Property Trust
STWD
$6.15B
$86K ﹤0.01%
4,000
-5,802
-59% -$138K
ALV icon
1332
Autoliv
ALV
$8.76B
$85K ﹤0.01%
1,029
EWJ icon
1333
iShares MSCI Japan ETF
EWJ
$21.7B
$85K ﹤0.01%
1,677
+1,135
+209% +$59.1K
VRTX icon
1334
Vertex Pharmaceuticals
VRTX
$122B
$85K ﹤0.01%
704
-25,470
-97% -$3.21M
FTNT icon
1335
Fortinet
FTNT
$112B
$84K ﹤0.01%
10,325
+1,500
+17% +$11.6K
FXA icon
1336
Invesco CurrencyShares Australian Dollar Trust
FXA
$97M
$84K ﹤0.01%
1,100
SAVE
1337
DELISTED
Spirit Airlines, Inc.
SAVE
$84K ﹤0.01%
1,380
-5,839
-81% -$398K
CPRI icon
1338
Capri Holdings
CPRI
$1.82B
$83K ﹤0.01%
2,003
+16
+0.8% +$902
RWM icon
1339
ProShares Short Russell2000
RWM
$132M
$83K ﹤0.01%
1,435
-1
-0.1% -$58
ECOL
1340
DELISTED
US Ecology, Inc.
ECOL
$83K ﹤0.01%
1,712
-1,500
-47% -$72.4K
INZ.CL
1341
DELISTED
Ing Groep N.v.
INZ.CL
$83K ﹤0.01%
3,230
SPXC icon
1342
SPX Corp
SPXC
$11B
$81K ﹤0.01%
4,511
-3,399
-43% -$66.3K
SFLY
1343
DELISTED
Shutterfly, Inc.
SFLY
$81K ﹤0.01%
1,720
-2,090
-55% -$96.9K
ADT
1344
DELISTED
ADT Corp
ADT
$81K ﹤0.01%
2,458
+300
+14% +$11.4K
ACGL icon
1345
Arch Capital
ACGL
$36.3B
$80K ﹤0.01%
3,600
AMLP icon
1346
Alerian MLP ETF
AMLP
$12.7B
$80K ﹤0.01%
1,040
DLB icon
1347
Dolby
DLB
$4.85B
$80K ﹤0.01%
+2,037
New +$80.7K
SGOL icon
1348
abrdn Physical Gold Shares ETF
SGOL
$6.97B
$80K ﹤0.01%
7,000
XBI icon
1349
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$80K ﹤0.01%
960
+810
+540% +$63K
FNF icon
1350
Fidelity National Financial
FNF
$14B
$79K ﹤0.01%
3,117

Similar funds

Glenmede Trust's Q2 2015 Portfolio in Review

As of Q2 2015, Glenmede Trust held 3,080 positions worth $13.9B, up 1.1% from $13.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust's Q2 2015 filing shows 521 new, 857 increased, 739 reduced and 172 closed positions. Its largest new stake was Iridium Communications: 2,746,232 shares worth $25M. The largest sale was Oracle, an estimated $47.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Glenmede Trust's largest Q2 2015 buy was Iridium Communications: 2,746,232 shares worth $25M.
  • Glenmede Trust added most to Microsoft in Q2 2015, an estimated $44.4M increase.
  • Glenmede Trust's biggest Q2 2015 reduction was Oracle, cutting an estimated $47.1M.
  • Glenmede Trust fully exited Triumph Group in Q2 2015, selling an estimated $30M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.9B portfolio in Q2 2015.
  • Glenmede Trust opened 521 new positions and closed 172 in Q2 2015.
  • Glenmede Trust's portfolio value rose 1.1% quarter-over-quarter to $13.9B.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.